Global IBS-C Drugs Market Size, Status and Forecast 2020-2026

Global IBS-C Drugs Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by IBS-C Drugs Revenue
1.4 Market by Type
1.4.1 Global IBS-C Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Linaclotide
1.4.3 Lubiprostone
1.4.4 Osmotic Laxatives
1.4.5 Stimulant Laxatives
1.4.6 Other
1.5 Market by Application
1.5.1 Global IBS-C Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global IBS-C Drugs Market Perspective (2015-2026)
2.2 Global IBS-C Drugs Growth Trends by Regions
2.2.1 IBS-C Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 IBS-C Drugs Historic Market Share by Regions (2015-2020)
2.2.3 IBS-C Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 IBS-C Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key IBS-C Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top IBS-C Drugs Players by Market Size
3.1.1 Global Top IBS-C Drugs Players by Revenue (2015-2020)
3.1.2 Global IBS-C Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global IBS-C Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global IBS-C Drugs Market Concentration Ratio
3.2.1 Global IBS-C Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by IBS-C Drugs Revenue in 2019
3.3 IBS-C Drugs Key Players Head office and Area Served
3.4 Key Players IBS-C Drugs Product Solution and Service
3.5 Date of Enter into IBS-C Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global IBS-C Drugs Historic Market Size by Type (2015-2020)
4.2 Global IBS-C Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global IBS-C Drugs Market Size by Application (2015-2020)
5.2 Global IBS-C Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America IBS-C Drugs Market Size (2015-2020)
6.2 IBS-C Drugs Key Players in North America (2019-2020)
6.3 North America IBS-C Drugs Market Size by Type (2015-2020)
6.4 North America IBS-C Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe IBS-C Drugs Market Size (2015-2020)
7.2 IBS-C Drugs Key Players in Europe (2019-2020)
7.3 Europe IBS-C Drugs Market Size by Type (2015-2020)
7.4 Europe IBS-C Drugs Market Size by Application (2015-2020)
8 China
8.1 China IBS-C Drugs Market Size (2015-2020)
8.2 IBS-C Drugs Key Players in China (2019-2020)
8.3 China IBS-C Drugs Market Size by Type (2015-2020)
8.4 China IBS-C Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan IBS-C Drugs Market Size (2015-2020)
9.2 IBS-C Drugs Key Players in Japan (2019-2020)
9.3 Japan IBS-C Drugs Market Size by Type (2015-2020)
9.4 Japan IBS-C Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia IBS-C Drugs Market Size (2015-2020)
10.2 IBS-C Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia IBS-C Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia IBS-C Drugs Market Size by Application (2015-2020)
11 India
11.1 India IBS-C Drugs Market Size (2015-2020)
11.2 IBS-C Drugs Key Players in India (2019-2020)
11.3 India IBS-C Drugs Market Size by Type (2015-2020)
11.4 India IBS-C Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America IBS-C Drugs Market Size (2015-2020)
12.2 IBS-C Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America IBS-C Drugs Market Size by Type (2015-2020)
12.4 Central & South America IBS-C Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Catalent Pharmaceuticals Solutions
13.1.1 Catalent Pharmaceuticals Solutions Company Details
13.1.2 Catalent Pharmaceuticals Solutions Business Overview
13.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Introduction
13.1.4 Catalent Pharmaceuticals Solutions Revenue in IBS-C Drugs Business (2015-2020))
13.1.5 Catalent Pharmaceuticals Solutions Recent Development
13.2 Nestle
13.2.1 Nestle Company Details
13.2.2 Nestle Business Overview
13.2.3 Nestle IBS-C Drugs Introduction
13.2.4 Nestle Revenue in IBS-C Drugs Business (2015-2020)
13.2.5 Nestle Recent Development
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Details
13.3.2 Abbott Laboratories Business Overview
13.3.3 Abbott Laboratories IBS-C Drugs Introduction
13.3.4 Abbott Laboratories Revenue in IBS-C Drugs Business (2015-2020)
13.3.5 Abbott Laboratories Recent Development
13.4 Synergy Pharmaceuticals
13.4.1 Synergy Pharmaceuticals Company Details
13.4.2 Synergy Pharmaceuticals Business Overview
13.4.3 Synergy Pharmaceuticals IBS-C Drugs Introduction
13.4.4 Synergy Pharmaceuticals Revenue in IBS-C Drugs Business (2015-2020)
13.4.5 Synergy Pharmaceuticals Recent Development
13.5 Sucampo Pharmaceuticals
13.5.1 Sucampo Pharmaceuticals Company Details
13.5.2 Sucampo Pharmaceuticals Business Overview
13.5.3 Sucampo Pharmaceuticals IBS-C Drugs Introduction
13.5.4 Sucampo Pharmaceuticals Revenue in IBS-C Drugs Business (2015-2020)
13.5.5 Sucampo Pharmaceuticals Recent Development
13.6 Novartis Pharma Ag
13.6.1 Novartis Pharma Ag Company Details
13.6.2 Novartis Pharma Ag Business Overview
13.6.3 Novartis Pharma Ag IBS-C Drugs Introduction
13.6.4 Novartis Pharma Ag Revenue in IBS-C Drugs Business (2015-2020)
13.6.5 Novartis Pharma Ag Recent Development
13.7 Astellas Pharmaceuticals
13.7.1 Astellas Pharmaceuticals Company Details
13.7.2 Astellas Pharmaceuticals Business Overview
13.7.3 Astellas Pharmaceuticals IBS-C Drugs Introduction
13.7.4 Astellas Pharmaceuticals Revenue in IBS-C Drugs Business (2015-2020)
13.7.5 Astellas Pharmaceuticals Recent Development
13.8 Ardelyx, Inc
13.8.1 Ardelyx, Inc Company Details
13.8.2 Ardelyx, Inc Business Overview
13.8.3 Ardelyx, Inc IBS-C Drugs Introduction
13.8.4 Ardelyx, Inc Revenue in IBS-C Drugs Business (2015-2020)
13.8.5 Ardelyx, Inc Recent Development
13.9 Synthetic Biologics, Inc
13.9.1 Synthetic Biologics, Inc Company Details
13.9.2 Synthetic Biologics, Inc Business Overview
13.9.3 Synthetic Biologics, Inc IBS-C Drugs Introduction
13.9.4 Synthetic Biologics, Inc Revenue in IBS-C Drugs Business (2015-2020)
13.9.5 Synthetic Biologics, Inc Recent Development
13.10 Teva Pharmaceutical Industries
13.10.1 Teva Pharmaceutical Industries Company Details
13.10.2 Teva Pharmaceutical Industries Business Overview
13.10.3 Teva Pharmaceutical Industries IBS-C Drugs Introduction
13.10.4 Teva Pharmaceutical Industries Revenue in IBS-C Drugs Business (2015-2020)
13.10.5 Teva Pharmaceutical Industries Recent Development
13.11 Bama-Geve, SLU
10.11.1 Bama-Geve, SLU Company Details
10.11.2 Bama-Geve, SLU Business Overview
10.11.3 Bama-Geve, SLU IBS-C Drugs Introduction
10.11.4 Bama-Geve, SLU Revenue in IBS-C Drugs Business (2015-2020)
10.11.5 Bama-Geve, SLU Recent Development
13.12 Ferring BV
10.12.1 Ferring BV Company Details
10.12.2 Ferring BV Business Overview
10.12.3 Ferring BV IBS-C Drugs Introduction
10.12.4 Ferring BV Revenue in IBS-C Drugs Business (2015-2020)
10.12.5 Ferring BV Recent Development
13.13 Ironwood Pharmaceuticals, Inc
10.13.1 Ironwood Pharmaceuticals, Inc Company Details
10.13.2 Ironwood Pharmaceuticals, Inc Business Overview
10.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Introduction
10.13.4 Ironwood Pharmaceuticals, Inc Revenue in IBS-C Drugs Business (2015-2020)
10.13.5 Ironwood Pharmaceuticals, Inc Recent Development
13.14 Salix Pharmaceuticals Ltd
10.14.1 Salix Pharmaceuticals Ltd Company Details
10.14.2 Salix Pharmaceuticals Ltd Business Overview
10.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Introduction
10.14.4 Salix Pharmaceuticals Ltd Revenue in IBS-C Drugs Business (2015-2020)
10.14.5 Salix Pharmaceuticals Ltd Recent Development
13.15 Norgine B.V
10.15.1 Norgine B.V Company Details
10.15.2 Norgine B.V Business Overview
10.15.3 Norgine B.V IBS-C Drugs Introduction
10.15.4 Norgine B.V Revenue in IBS-C Drugs Business (2015-2020)
10.15.5 Norgine B.V Recent Development
13.16 Prometheus Laboratories Inc
10.16.1 Prometheus Laboratories Inc Company Details
10.16.2 Prometheus Laboratories Inc Business Overview
10.16.3 Prometheus Laboratories Inc IBS-C Drugs Introduction
10.16.4 Prometheus Laboratories Inc Revenue in IBS-C Drugs Business (2015-2020)
10.16.5 Prometheus Laboratories Inc Recent Development
13.17 Actavis Nordic A/S
10.17.1 Actavis Nordic A/S Company Details
10.17.2 Actavis Nordic A/S Business Overview
10.17.3 Actavis Nordic A/S IBS-C Drugs Introduction
10.17.4 Actavis Nordic A/S Revenue in IBS-C Drugs Business (2015-2020)
10.17.5 Actavis Nordic A/S Recent Development
13.18 Albireo Pharma Inc
10.18.1 Albireo Pharma Inc Company Details
10.18.2 Albireo Pharma Inc Business Overview
10.18.3 Albireo Pharma Inc IBS-C Drugs Introduction
10.18.4 Albireo Pharma Inc Revenue in IBS-C Drugs Business (2015-2020)
10.18.5 Albireo Pharma Inc Recent Development
13.19 Yuhan Corp
10.19.1 Yuhan Corp Company Details
10.19.2 Yuhan Corp Business Overview
10.19.3 Yuhan Corp IBS-C Drugs Introduction
10.19.4 Yuhan Corp Revenue in IBS-C Drugs Business (2015-2020)
10.19.5 Yuhan Corp Recent Development
13.20 Astrazeneca Plc
10.20.1 Astrazeneca Plc Company Details
10.20.2 Astrazeneca Plc Business Overview
10.20.3 Astrazeneca Plc IBS-C Drugs Introduction
10.20.4 Astrazeneca Plc Revenue in IBS-C Drugs Business (2015-2020)
10.20.5 Astrazeneca Plc Recent Development
13.21 The Menarini Group
10.21.1 The Menarini Group Company Details
10.21.2 The Menarini Group Business Overview
10.21.3 The Menarini Group IBS-C Drugs Introduction
10.21.4 The Menarini Group Revenue in IBS-C Drugs Business (2015-2020)
10.21.5 The Menarini Group Recent Development
13.22 Ono Pharmaceutical Co., Ltd
10.22.1 Ono Pharmaceutical Co., Ltd Company Details
10.22.2 Ono Pharmaceutical Co., Ltd Business Overview
10.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Introduction
10.22.4 Ono Pharmaceutical Co., Ltd Revenue in IBS-C Drugs Business (2015-2020)
10.22.5 Ono Pharmaceutical Co., Ltd Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. IBS-C Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by IBS-C Drugs Revenue
Table 3. Ranking of Global Top IBS-C Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global IBS-C Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Linaclotide
Table 6. Key Players of Lubiprostone
Table 7. Key Players of Osmotic Laxatives
Table 8. Key Players of Stimulant Laxatives
Table 9. Key Players of Other
Table 10. Global IBS-C Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global IBS-C Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global IBS-C Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global IBS-C Drugs Market Share by Regions (2015-2020)
Table 14. Global IBS-C Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global IBS-C Drugs Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. IBS-C Drugs Market Growth Strategy
Table 20. Main Points Interviewed from Key IBS-C Drugs Players
Table 21. Global IBS-C Drugs Revenue by Players (2015-2020) (Million US$)
Table 22. Global IBS-C Drugs Market Share by Players (2015-2020)
Table 23. Global Top IBS-C Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IBS-C Drugs as of 2019)
Table 24. Global IBS-C Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players IBS-C Drugs Product Solution and Service
Table 27. Date of Enter into IBS-C Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global IBS-C Drugs Market Size by Type (2015-2020) (Million US$)
Table 30. Global IBS-C Drugs Market Size Share by Type (2015-2020)
Table 31. Global IBS-C Drugs Revenue Market Share by Type (2021-2026)
Table 32. Global IBS-C Drugs Market Size Share by Application (2015-2020)
Table 33. Global IBS-C Drugs Market Size by Application (2015-2020) (Million US$)
Table 34. Global IBS-C Drugs Market Size Share by Application (2021-2026)
Table 35. North America Key Players IBS-C Drugs Revenue (2019-2020) (Million US$)
Table 36. North America Key Players IBS-C Drugs Market Share (2019-2020)
Table 37. North America IBS-C Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. North America IBS-C Drugs Market Share by Type (2015-2020)
Table 39. North America IBS-C Drugs Market Size by Application (2015-2020) (Million US$)
Table 40. North America IBS-C Drugs Market Share by Application (2015-2020)
Table 41. Europe Key Players IBS-C Drugs Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players IBS-C Drugs Market Share (2019-2020)
Table 43. Europe IBS-C Drugs Market Size by Type (2015-2020) (Million US$)
Table 44. Europe IBS-C Drugs Market Share by Type (2015-2020)
Table 45. Europe IBS-C Drugs Market Size by Application (2015-2020) (Million US$)
Table 46. Europe IBS-C Drugs Market Share by Application (2015-2020)
Table 47. China Key Players IBS-C Drugs Revenue (2019-2020) (Million US$)
Table 48. China Key Players IBS-C Drugs Market Share (2019-2020)
Table 49. China IBS-C Drugs Market Size by Type (2015-2020) (Million US$)
Table 50. China IBS-C Drugs Market Share by Type (2015-2020)
Table 51. China IBS-C Drugs Market Size by Application (2015-2020) (Million US$)
Table 52. China IBS-C Drugs Market Share by Application (2015-2020)
Table 53. Japan Key Players IBS-C Drugs Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players IBS-C Drugs Market Share (2019-2020)
Table 55. Japan IBS-C Drugs Market Size by Type (2015-2020) (Million US$)
Table 56. Japan IBS-C Drugs Market Share by Type (2015-2020)
Table 57. Japan IBS-C Drugs Market Size by Application (2015-2020) (Million US$)
Table 58. Japan IBS-C Drugs Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players IBS-C Drugs Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players IBS-C Drugs Market Share (2019-2020)
Table 61. Southeast Asia IBS-C Drugs Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia IBS-C Drugs Market Share by Type (2015-2020)
Table 63. Southeast Asia IBS-C Drugs Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia IBS-C Drugs Market Share by Application (2015-2020)
Table 65. India Key Players IBS-C Drugs Revenue (2019-2020) (Million US$)
Table 66. India Key Players IBS-C Drugs Market Share (2019-2020)
Table 67. India IBS-C Drugs Market Size by Type (2015-2020) (Million US$)
Table 68. India IBS-C Drugs Market Share by Type (2015-2020)
Table 69. India IBS-C Drugs Market Size by Application (2015-2020) (Million US$)
Table 70. India IBS-C Drugs Market Share by Application (2015-2020)
Table 71. Central & South America Key Players IBS-C Drugs Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players IBS-C Drugs Market Share (2019-2020)
Table 73. Central & South America IBS-C Drugs Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America IBS-C Drugs Market Share by Type (2015-2020)
Table 75. Central & South America IBS-C Drugs Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America IBS-C Drugs Market Share by Application (2015-2020)
Table 77. Catalent Pharmaceuticals Solutions Company Details
Table 78. Catalent Pharmaceuticals Solutions Business Overview
Table 79. Catalent Pharmaceuticals Solutions Product
Table 80. Catalent Pharmaceuticals Solutions Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 81. Catalent Pharmaceuticals Solutions Recent Development
Table 82. Nestle Company Details
Table 83. Nestle Business Overview
Table 84. Nestle Product
Table 85. Nestle Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 86. Nestle Recent Development
Table 87. Abbott Laboratories Company Details
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Product
Table 90. Abbott Laboratories Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 91. Abbott Laboratories Recent Development
Table 92. Synergy Pharmaceuticals Company Details
Table 93. Synergy Pharmaceuticals Business Overview
Table 94. Synergy Pharmaceuticals Product
Table 95. Synergy Pharmaceuticals Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 96. Synergy Pharmaceuticals Recent Development
Table 97. Sucampo Pharmaceuticals Company Details
Table 98. Sucampo Pharmaceuticals Business Overview
Table 99. Sucampo Pharmaceuticals Product
Table 100. Sucampo Pharmaceuticals Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 101. Sucampo Pharmaceuticals Recent Development
Table 102. Novartis Pharma Ag Company Details
Table 103. Novartis Pharma Ag Business Overview
Table 104. Novartis Pharma Ag Product
Table 105. Novartis Pharma Ag Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 106. Novartis Pharma Ag Recent Development
Table 107. Astellas Pharmaceuticals Company Details
Table 108. Astellas Pharmaceuticals Business Overview
Table 109. Astellas Pharmaceuticals Product
Table 110. Astellas Pharmaceuticals Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 111. Astellas Pharmaceuticals Recent Development
Table 112. Ardelyx, Inc Business Overview
Table 113. Ardelyx, Inc Product
Table 114. Ardelyx, Inc Company Details
Table 115. Ardelyx, Inc Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 116. Ardelyx, Inc Recent Development
Table 117. Synthetic Biologics, Inc Company Details
Table 118. Synthetic Biologics, Inc Business Overview
Table 119. Synthetic Biologics, Inc Product
Table 120. Synthetic Biologics, Inc Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 121. Synthetic Biologics, Inc Recent Development
Table 122. Teva Pharmaceutical Industries Company Details
Table 123. Teva Pharmaceutical Industries Business Overview
Table 124. Teva Pharmaceutical Industries Product
Table 125. Teva Pharmaceutical Industries Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 126. Teva Pharmaceutical Industries Recent Development
Table 127. Bama-Geve, SLU Company Details
Table 128. Bama-Geve, SLU Business Overview
Table 129. Bama-Geve, SLU Product
Table 130. Bama-Geve, SLU Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 131. Bama-Geve, SLU Recent Development
Table 132. Ferring BV Company Details
Table 133. Ferring BV Business Overview
Table 134. Ferring BV Product
Table 135. Ferring BV Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 136. Ferring BV Recent Development
Table 137. Ironwood Pharmaceuticals, Inc Company Details
Table 138. Ironwood Pharmaceuticals, Inc Business Overview
Table 139. Ironwood Pharmaceuticals, Inc Product
Table 140. Ironwood Pharmaceuticals, Inc Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 141. Ironwood Pharmaceuticals, Inc Recent Development
Table 142. Salix Pharmaceuticals Ltd Company Details
Table 143. Salix Pharmaceuticals Ltd Business Overview
Table 144. Salix Pharmaceuticals Ltd Product
Table 145. Salix Pharmaceuticals Ltd Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 146. Salix Pharmaceuticals Ltd Recent Development
Table 147. Norgine B.V Company Details
Table 148. Norgine B.V Business Overview
Table 149. Norgine B.V Product
Table 150. Norgine B.V Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 151. Norgine B.V Recent Development
Table 152. Prometheus Laboratories Inc Company Details
Table 153. Prometheus Laboratories Inc Business Overview
Table 154. Prometheus Laboratories Inc Product
Table 155. Prometheus Laboratories Inc Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 156. Prometheus Laboratories Inc Recent Development
Table 157. Actavis Nordic A/S Company Details
Table 158. Actavis Nordic A/S Business Overview
Table 159. Actavis Nordic A/S Product
Table 160. Actavis Nordic A/S Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 161. Actavis Nordic A/S Recent Development
Table 162. Albireo Pharma Inc Company Details
Table 163. Albireo Pharma Inc Business Overview
Table 164. Albireo Pharma Inc Product
Table 165. Albireo Pharma Inc Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 166. Albireo Pharma Inc Recent Development
Table 167. Yuhan Corp Company Details
Table 168. Yuhan Corp Business Overview
Table 169. Yuhan Corp Product
Table 170. Yuhan Corp Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 171. Yuhan Corp Recent Development
Table 172. Astrazeneca Plc Company Details
Table 173. Astrazeneca Plc Business Overview
Table 174. Astrazeneca Plc Product
Table 175. Astrazeneca Plc Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 176. Astrazeneca Plc Recent Development
Table 177. The Menarini Group Company Details
Table 178. The Menarini Group Business Overview
Table 179. The Menarini Group Product
Table 180. The Menarini Group Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 181. The Menarini Group Recent Development
Table 182. Ono Pharmaceutical Co., Ltd Company Details
Table 183. Ono Pharmaceutical Co., Ltd Business Overview
Table 184. Ono Pharmaceutical Co., Ltd Product
Table 185. Ono Pharmaceutical Co., Ltd Revenue in IBS-C Drugs Business (2015-2020) (Million US$)
Table 186. Ono Pharmaceutical Co., Ltd Recent Development
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IBS-C Drugs Market Share by Type: 2020 VS 2026
Figure 2. Linaclotide Features
Figure 3. Lubiprostone Features
Figure 4. Osmotic Laxatives Features
Figure 5. Stimulant Laxatives Features
Figure 6. Other Features
Figure 7. Global IBS-C Drugs Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. IBS-C Drugs Report Years Considered
Figure 12. Global IBS-C Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global IBS-C Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global IBS-C Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global IBS-C Drugs Market Share by Players in 2019
Figure 17. Global Top IBS-C Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IBS-C Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by IBS-C Drugs Revenue in 2019
Figure 19. North America IBS-C Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe IBS-C Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China IBS-C Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan IBS-C Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia IBS-C Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India IBS-C Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America IBS-C Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs